ID   DLG4_RAT                Reviewed;         724 AA.
AC   P31016; P97631;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   02-OCT-2024, entry version 242.
DE   RecName: Full=Disks large homolog 4;
DE   AltName: Full=Postsynaptic density protein 95 {ECO:0000305};
DE            Short=PSD-95 {ECO:0000303|PubMed:20962234};
DE   AltName: Full=Synapse-associated protein 90;
DE            Short=SAP-90;
DE            Short=SAP90;
GN   Name=Dlg4 {ECO:0000312|RGD:68424};
GN   Synonyms=Dlgh4, Psd95 {ECO:0000303|PubMed:27756895};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=1419001; DOI=10.1016/0896-6273(92)90245-9;
RA   Cho K.-O., Hunt C.A., Kennedy M.B.;
RT   "The rat brain postsynaptic density fraction contains a homolog of the
RT   Drosophila discs-large tumor suppressor protein.";
RL   Neuron 9:929-942(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7680343; DOI=10.1016/s0021-9258(18)53433-5;
RA   Kistner U., Wenzel B.M., Veh R.W., Cases-Langhoff C., Garner A.M.,
RA   Appeltauer U., Voss B., Gundelfinger E.D., Garner C.C.;
RT   "SAP90, a rat presynaptic protein related to the product of the Drosophila
RT   tumor suppressor gene dlg-A.";
RL   J. Biol. Chem. 268:4580-4583(1993).
RN   [3]
RP   PROTEIN SEQUENCE OF 113-126; 212-233; 300-312; 381-399 AND 598-617, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Diao W.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 566-625.
RC   STRAIN=Wistar Kyoto; TISSUE=Vascular smooth muscle;
RA   Adams L.D., Werny I., Schwartz S.M.;
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   INTERACTION WITH GRIN2A; GRIN2B; GRIN2C AND GRIN2D.
RX   PubMed=7569905; DOI=10.1126/science.7569905;
RA   Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H.;
RT   "Domain interaction between NMDA receptor subunits and the postsynaptic
RT   density protein PSD-95.";
RL   Science 269:1737-1740(1995).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=8922396; DOI=10.1523/jneurosci.16-23-07407.1996;
RA   Brenman J.E., Christopherson K.S., Craven S.E., McGee A.W., Bredt D.S.;
RT   "Cloning and characterization of postsynaptic density 93, a nitric oxide
RT   synthase interacting protein.";
RL   J. Neurosci. 16:7407-7415(1996).
RN   [7]
RP   INTERACTION WITH DLGAP1; DLGAP2; DLGAP3 AND DLGAP4, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Brain;
RX   PubMed=9115257; DOI=10.1074/jbc.272.18.11943;
RA   Takeuchi M., Hata Y., Hirao K., Toyoda A., Irie M., Takai Y.;
RT   "SAPAPs. A family of PSD-95/SAP90-associated proteins localized at
RT   postsynaptic density.";
RL   J. Biol. Chem. 272:11943-11951(1997).
RN   [8]
RP   INTERACTION WITH BEGAIN AND DLGAP1.
RX   PubMed=9756850; DOI=10.1074/jbc.273.41.26269;
RA   Deguchi M., Hata Y., Takeuchi M., Ide N., Hirao K., Yao I., Irie M.,
RA   Toyoda A., Takai Y.;
RT   "BEGAIN (brain-enriched guanylate kinase-associated protein), a novel
RT   neuronal PSD-95/SAP90-binding protein.";
RL   J. Biol. Chem. 273:26269-26272(1998).
RN   [9]
RP   INTERACTION WITH MAP1A.
RX   PubMed=9786987; DOI=10.1523/jneurosci.18-21-08805.1998;
RA   Brenman J.E., Topinka J.R., Cooper E.C., McGee A.W., Rosen J., Milroy T.,
RA   Ralston H.J., Bredt D.S.;
RT   "Localization of postsynaptic density-93 to dendritic microtubules and
RT   interaction with microtubule-associated protein 1A.";
RL   J. Neurosci. 18:8805-8813(1998).
RN   [10]
RP   INTERACTION WITH SYNGAP1.
RX   PubMed=9581761; DOI=10.1016/s0896-6273(00)81008-9;
RA   Kim J.H., Liao D., Lau L.-F., Huganir R.L.;
RT   "SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein
RT   family.";
RL   Neuron 20:683-691(1998).
RN   [11]
RP   INTERACTION WITH CRIPT.
RX   PubMed=9581762; DOI=10.1016/s0896-6273(00)81009-0;
RA   Niethammer M., Valtschanoff J.G., Kapoor T.M., Allison D.W., Weinberg R.J.,
RA   Craig A.M., Sheng M.;
RT   "CRIPT, a novel postsynaptic protein that binds to the third PDZ domain of
RT   PSD-95/SAP90.";
RL   Neuron 20:693-707(1998).
RN   [12]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF CYS-3 AND CYS-5, AND PALMITOYLATION AT
RP   CYS-3 AND CYS-5.
RX   PubMed=10629226; DOI=10.1083/jcb.148.1.159;
RA   El-Husseini A.E., Craven S.E., Chetkovich D.M., Firestein B.L., Schnell E.,
RA   Aoki C., Bredt D.S.;
RT   "Dual palmitoylation of PSD-95 mediates its vesiculotubular sorting,
RT   postsynaptic targeting, and ion channel clustering.";
RL   J. Cell Biol. 148:159-172(2000).
RN   [13]
RP   INTERACTION WITH SEMA4C.
RX   PubMed=11134026; DOI=10.1074/jbc.m009051200;
RA   Inagaki S., Ohoka Y., Sugimoto H., Fujioka S., Amazaki M., Kurinami H.,
RA   Miyazaki N., Tohyama M., Furuyama T.;
RT   "Sema4c, a transmembrane semaphorin, interacts with a post-synaptic density
RT   protein, PSD-95.";
RL   J. Biol. Chem. 276:9174-9181(2001).
RN   [14]
RP   INTERACTION WITH SEMA4F, AND SUBCELLULAR LOCATION.
RX   PubMed=11483650; DOI=10.1046/j.1471-4159.2001.00447.x;
RA   Schultze W., Eulenburg V., Lessmann V., Herrmann L., Dittmar T.,
RA   Gundelfinger E.D., Heumann R., Erdmann K.S.;
RT   "Semaphorin4F interacts with the synapse-associated protein SAP90/PSD-95.";
RL   J. Neurochem. 78:482-489(2001).
RN   [15]
RP   INTERACTION WITH SIPA1L1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11502259; DOI=10.1016/s0896-6273(01)00355-5;
RA   Pak D.T., Yang S., Rudolph-Correia S., Kim E., Sheng M.;
RT   "Regulation of dendritic spine morphology by SPAR, a PSD-95-associated
RT   RapGAP.";
RL   Neuron 31:289-303(2001).
RN   [16]
RP   INTERACTION WITH KCND2.
RX   PubMed=11923279; DOI=10.1074/jbc.m109412200;
RA   Wong W., Newell E.W., Jugloff D.G.M., Jones O.T., Schlichter L.C.;
RT   "Cell surface targeting and clustering interactions between heterologously
RT   expressed PSD-95 and the Shal voltage-gated potassium channel, Kv4.2.";
RL   J. Biol. Chem. 277:20423-20430(2002).
RN   [17]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=12151521; DOI=10.1523/jneurosci.22-15-06415.2002;
RA   Chetkovich D.M., Bunn R.C., Kuo S.-H., Kawasaki Y., Kohwi M., Bredt D.S.;
RT   "Postsynaptic targeting of alternative postsynaptic density-95 isoforms by
RT   distinct mechanisms.";
RL   J. Neurosci. 22:6415-6425(2002).
RN   [18]
RP   INTERACTION WITH KCNJ4, AND SUBCELLULAR LOCATION.
RX   PubMed=11997254; DOI=10.1152/ajpcell.00615.2001;
RA   Inanobe A., Fujita A., Ito M., Tomoike H., Inageda K., Kurachi Y.;
RT   "Inward rectifier K+ channel Kir2.3 is localized at the postsynaptic
RT   membrane of excitatory synapses.";
RL   Am. J. Physiol. 282:C1396-C1403(2002).
RN   [19]
RP   SUBCELLULAR LOCATION, UBIQUITINATION, AND MUTAGENESIS OF 13-ARG--HIS-24.
RX   PubMed=14642282; DOI=10.1016/s0896-6273(03)00687-1;
RA   Colledge M., Snyder E.M., Crozier R.A., Soderling J.A., Jin Y.,
RA   Langeberg L.K., Lu H., Bear M.F., Scott J.D.;
RT   "Ubiquitination regulates PSD-95 degradation and AMPA receptor surface
RT   expression.";
RL   Neuron 40:595-607(2003).
RN   [20]
RP   INTERACTION WITH ASIC3, AND FUNCTION.
RX   PubMed=15317815; DOI=10.1074/jbc.m405874200;
RA   Hruska-Hageman A.M., Benson C.J., Leonard A.S., Price M.P., Welsh M.J.;
RT   "PSD-95 and Lin-7b interact with acid-sensing ion channel-3 and have
RT   opposite effects on H+- gated current.";
RL   J. Biol. Chem. 279:46962-46968(2004).
RN   [21]
RP   INTERACTION WITH CXADR.
RX   PubMed=15304526; DOI=10.1242/jcs.01300;
RA   Ashbourne-Excoffon K.J.D., Hruska-Hageman A.M., Klotz M., Traver G.L.,
RA   Zabner J.;
RT   "A role for the PDZ-binding domain of the coxsackie B virus and adenovirus
RT   receptor (CAR) in cell adhesion and growth.";
RL   J. Cell Sci. 117:4401-4409(2004).
RN   [22]
RP   PALMITOYLATION.
RX   PubMed=15603741; DOI=10.1016/j.neuron.2004.12.005;
RA   Fukata M., Fukata Y., Adesnik H., Nicoll R.A., Bredt D.S.;
RT   "Identification of PSD-95 palmitoylating enzymes.";
RL   Neuron 44:987-996(2004).
RN   [23]
RP   FUNCTION.
RX   PubMed=15358863; DOI=10.1073/pnas.0405939101;
RA   Prange O., Wong T.P., Gerrow K., Wang Y.T., El-Husseini A.;
RT   "A balance between excitatory and inhibitory synapses is controlled by PSD-
RT   95 and neuroligin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:13915-13920(2004).
RN   [24]
RP   INTERACTION WITH PRR7.
RX   PubMed=15629447; DOI=10.1016/j.bbrc.2004.11.154;
RA   Murata Y., Doi T., Taniguchi H., Fujiyoshi Y.;
RT   "Proteomic analysis revealed a novel synaptic proline-rich membrane protein
RT   (PRR7) associated with PSD-95 and NMDA receptor.";
RL   Biochem. Biophys. Res. Commun. 327:183-191(2005).
RN   [25]
RP   INTERACTION WITH KLHL17.
RX   PubMed=16054660; DOI=10.1016/j.neuropharm.2005.05.022;
RA   Chen Y., Li M.;
RT   "Interactions between CAP70 and actinfilin are important for integrity of
RT   actin cytoskeleton structures in neurons.";
RL   Neuropharmacology 49:1026-1041(2005).
RN   [26]
RP   INTERACTION WITH LRFN2.
RX   PubMed=16495444; DOI=10.1523/jneurosci.3799-05.2006;
RA   Wang C.Y., Chang K., Petralia R.S., Wang Y.X., Seabold G.K., Wenthold R.J.;
RT   "A novel family of adhesion-like molecules that interacts with the NMDA
RT   receptor.";
RL   J. Neurosci. 26:2174-2183(2006).
RN   [27]
RP   INTERACTION WITH LRFN1.
RX   PubMed=16630835; DOI=10.1016/j.neuron.2006.04.005;
RA   Ko J., Kim S., Chung H.S., Kim K., Han K., Kim H., Jun H., Kaang B.-K.,
RA   Kim E.;
RT   "SALM synaptic cell adhesion-like molecules regulate the differentiation of
RT   excitatory synapses.";
RL   Neuron 50:233-245(2006).
RN   [28]
RP   INTERACTION WITH ADAM22 AND LGI1.
RX   PubMed=16990550; DOI=10.1126/science.1129947;
RA   Fukata Y., Adesnik H., Iwanaga T., Bredt D.S., Nicoll R.A., Fukata M.;
RT   "Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic
RT   transmission.";
RL   Science 313:1792-1795(2006).
RN   [29]
RP   INTERACTION WITH ANKS1B.
RX   PubMed=17334360; DOI=10.1038/nn1867;
RA   Jordan B.A., Fernholz B.D., Khatri L., Ziff E.B.;
RT   "Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers
RT   and protein synthesis in neurons.";
RL   Nat. Neurosci. 10:427-435(2007).
RN   [30]
RP   INTERACTION WITH FRMPD4.
RX   PubMed=19118189; DOI=10.1523/jneurosci.3112-08.2008;
RA   Lee H.W., Choi J., Shin H., Kim K., Yang J., Na M., Choi S.Y., Kang G.B.,
RA   Eom S.H., Kim H., Kim E.;
RT   "Preso, a novel PSD-95-interacting FERM and PDZ domain protein that
RT   regulates dendritic spine morphogenesis.";
RL   J. Neurosci. 28:14546-14556(2008).
RN   [31]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PALMITOYLATION BY ZDHHC2.
RX   PubMed=19596852; DOI=10.1083/jcb.200903101;
RA   Noritake J., Fukata Y., Iwanaga T., Hosomi N., Tsutsumi R., Matsuda N.,
RA   Tani H., Iwanari H., Mochizuki Y., Kodama T., Matsuura Y., Bredt D.S.,
RA   Hamakubo T., Fukata M.;
RT   "Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic
RT   targeting of PSD-95.";
RL   J. Cell Biol. 186:147-160(2009).
RN   [32]
RP   INTERACTION WITH PTEN, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=20628354; DOI=10.1038/emboj.2010.160;
RA   Jurado S., Benoist M., Lario A., Knafo S., Petrok C.N., Esteban J.A.;
RT   "PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent
RT   long-term depression.";
RL   EMBO J. 29:2827-2840(2010).
RN   [33]
RP   INTERACTION WITH ABR AND BCR, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=20962234; DOI=10.1523/jneurosci.1711-10.2010;
RA   Oh D., Han S., Seo J., Lee J.R., Choi J., Groffen J., Kim K., Cho Y.S.,
RA   Choi H.S., Shin H., Woo J., Won H., Park S.K., Kim S.Y., Jo J.,
RA   Whitcomb D.J., Cho K., Kim H., Bae Y.C., Heisterkamp N., Choi S.Y., Kim E.;
RT   "Regulation of synaptic Rac1 activity, long-term potentiation maintenance,
RT   and learning and memory by BCR and ABR Rac GTPase-activating proteins.";
RL   J. Neurosci. 30:14134-14144(2010).
RN   [34]
RP   INTERACTION WITH ADAM22, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND TISSUE SPECIFICITY.
RX   PubMed=20089912; DOI=10.1523/jneurosci.4661-09.2010;
RA   Ogawa Y., Oses-Prieto J., Kim M.Y., Horresh I., Peles E., Burlingame A.L.,
RA   Trimmer J.S., Meijer D., Rasband M.N.;
RT   "ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated
RT   guanylate kinases to juxtaparanodes of myelinated axons.";
RL   J. Neurosci. 30:1038-1048(2010).
RN   [35]
RP   INTERACTION WITH DGKI.
RX   PubMed=21119615; DOI=10.1038/emboj.2010.286;
RA   Yang J., Seo J., Nair R., Han S., Jang S., Kim K., Han K., Paik S.K.,
RA   Choi J., Lee S., Bae Y.C., Topham M.K., Prescott S.M., Rhee J.S.,
RA   Choi S.Y., Kim E.;
RT   "DGKiota regulates presynaptic release during mGluR-dependent LTD.";
RL   EMBO J. 30:165-180(2011).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-240; SER-295; SER-418;
RP   THR-420; SER-422; SER-449 AND SER-654, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [37]
RP   FUNCTION, AND INTERACTION WITH GPER1 AND NOS1.
RX   PubMed=23300088; DOI=10.1074/jbc.m112.412478;
RA   Akama K.T., Thompson L.I., Milner T.A., McEwen B.S.;
RT   "Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled
RT   receptor 30 (GPR30), an estrogen receptor that can be identified in
RT   hippocampal dendritic spines.";
RL   J. Biol. Chem. 288:6438-6450(2013).
RN   [38]
RP   FUNCTION, INTERACTION WITH GRIN2A AND RPH3A, AND SUBCELLULAR LOCATION.
RX   PubMed=26679993; DOI=10.1038/ncomms10181;
RA   Stanic J., Carta M., Eberini I., Pelucchi S., Marcello E., Genazzani A.A.,
RA   Racca C., Mulle C., Di Luca M., Gardoni F.;
RT   "Rabphilin 3A retains NMDA receptors at synaptic sites through interaction
RT   with GluN2A/PSD-95 complex.";
RL   Nat. Commun. 6:10181-10181(2015).
RN   [39]
RP   IDENTIFICATION IN A COMPLEX WITH PRR7 AND GRIN1, AND INTERACTION WITH PRR7.
RX   PubMed=27458189; DOI=10.15252/embj.201593070;
RA   Kravchick D.O., Karpova A., Hrdinka M., Lopez-Rojas J., Iacobas S.,
RA   Carbonell A.U., Iacobas D.A., Kreutz M.R., Jordan B.A.;
RT   "Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates
RT   NMDA-mediated excitotoxicity.";
RL   EMBO J. 35:1923-1934(2016).
RN   [40]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, PALMITOYLATION AT CYS-3 AND
RP   CYS-5, AND MUTAGENESIS OF CYS-3 AND CYS-5.
RX   PubMed=27307232; DOI=10.1523/jneurosci.0419-16.2016;
RA   Yokoi N., Fukata Y., Sekiya A., Murakami T., Kobayashi K., Fukata M.;
RT   "Identification of PSD-95 Depalmitoylating Enzymes.";
RL   J. Neurosci. 36:6431-6444(2016).
RN   [41]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH CACNG2 AND
RP   MPP2.
RX   PubMed=27756895; DOI=10.1038/srep35283;
RA   Rademacher N., Schmerl B., Lardong J.A., Wahl M.C., Shoichet S.A.;
RT   "MPP2 is a postsynaptic MAGUK scaffold protein that links SynCAM1 cell
RT   adhesion molecules to core components of the postsynaptic density.";
RL   Sci. Rep. 6:35283-35283(2016).
RN   [42]
RP   SUBCELLULAR LOCATION.
RX   PubMed=30021165; DOI=10.1016/j.celrep.2018.06.071;
RA   Stucchi R., Plucinska G., Hummel J.J.A., Zahavi E.E., Guerra San Juan I.,
RA   Klykov O., Scheltema R.A., Altelaar A.F.M., Hoogenraad C.C.;
RT   "Regulation of KIF1A-Driven Dense Core Vesicle Transport: Ca2+/CaM Controls
RT   DCV Binding and Liprin-alpha/TANC2 Recruits DCVs to Postsynaptic Sites.";
RL   Cell Rep. 24:685-700(2018).
RN   [43]
RP   PALMITOYLATION.
RX   PubMed=31189538; DOI=10.1242/jcs.230052;
RA   Shah B.S., Shimell J.J., Bamji S.X.;
RT   "Regulation of dendrite morphology and excitatory synapse formation by
RT   zDHHC15.";
RL   J. Cell Sci. 132:0-0(2019).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 302-402.
RX   PubMed=8674113; DOI=10.1016/s0092-8674(00)81307-0;
RA   Doyle D.A., Lee A., Lewis J., Kim E., Sheng M., Mackinnon R.;
RT   "Crystal structures of a complexed and peptide-free membrane protein-
RT   binding domain: molecular basis of peptide recognition by PDZ.";
RL   Cell 85:1067-1076(1996).
RN   [45]
RP   STRUCTURE BY NMR OF 155-246, AND INTERACTION WITH NOS1 AND CAPON.
RX   PubMed=10623522; DOI=10.1006/jmbi.1999.3350;
RA   Tochio H., Hung F., Li M., Bredt D.S., Zhang M.;
RT   "Solution structure and backbone dynamics of the second PDZ domain of
RT   postsynaptic density-95.";
RL   J. Mol. Biol. 295:225-237(2000).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 430-724.
RX   PubMed=11779504; DOI=10.1016/s1097-2765(01)00411-7;
RA   McGee A.W., Dakoji S.R., Olsen O., Bredt D.S., Lim W.A., Prehoda K.E.;
RT   "Structure of the SH3-guanylate kinase module from PSD-95 suggests a
RT   mechanism for regulated assembly of MAGUK scaffolding proteins.";
RL   Mol. Cell 8:1291-1301(2001).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 430-724.
RX   PubMed=11779506; DOI=10.1016/s1097-2765(01)00416-6;
RA   Tavares G.A., Panepucci E.H., Brunger A.T.;
RT   "Structural characterization of the intramolecular interaction between the
RT   SH3 and guanylate kinase domains of PSD-95.";
RL   Mol. Cell 8:1313-1325(2001).
RN   [48]
RP   STRUCTURE BY NMR OF 62-154 IN COMPLEX WITH CYCLIC PEPTIDE.
RX   PubMed=15123241; DOI=10.1016/j.chembiol.2004.03.013;
RA   Piserchio A., Salinas G.D., Li T., Marshall J., Spaller M.R., Mierke D.F.;
RT   "Targeting specific PDZ domains of PSD-95; structural basis for enhanced
RT   affinity and enzymatic stability of a cyclic peptide.";
RL   Chem. Biol. 11:469-473(2004).
RN   [49]
RP   STRUCTURE BY NMR OF 61-249 IN COMPLEX WITH PEPTIDE.
RX   PubMed=19072119; DOI=10.1021/ja8076022;
RA   Wang W., Weng J., Zhang X., Liu M., Zhang M.;
RT   "Creating conformational entropy by increasing interdomain mobility in
RT   ligand binding regulation: a revisit to N-terminal tandem PDZ domains of
RT   PSD-95.";
RL   J. Am. Chem. Soc. 131:787-796(2009).
CC   -!- FUNCTION: Postsynaptic scaffolding protein that plays a critical role
CC       in synaptogenesis and synaptic plasticity by providing a platform for
CC       the postsynaptic clustering of crucial synaptic proteins
CC       (PubMed:15317815, PubMed:15358863, PubMed:19596852, PubMed:20628354,
CC       PubMed:23300088, PubMed:26679993). Interacts with the cytoplasmic tail
CC       of NMDA receptor subunits and shaker-type potassium channels. Required
CC       for synaptic plasticity associated with NMDA receptor signaling.
CC       Overexpression or depletion of DLG4 changes the ratio of excitatory to
CC       inhibitory synapses in hippocampal neurons. May reduce the amplitude of
CC       ASIC3 acid-evoked currents by retaining the channel intracellularly.
CC       May regulate the intracellular trafficking of ADR1B (By similarity).
CC       Also regulates AMPA-type glutamate receptor (AMPAR) immobilization at
CC       postsynaptic density keeping the channels in an activated state in the
CC       presence of glutamate and preventing synaptic depression
CC       (PubMed:19596852). Under basal conditions, cooperates with FYN to
CC       stabilize palmitoyltransferase ZDHHC5 at the synaptic membrane through
CC       FYN-mediated phosphorylation of ZDHHC5 and its subsequent inhibition of
CC       association with endocytic proteins (By similarity).
CC       {ECO:0000250|UniProtKB:P78352, ECO:0000250|UniProtKB:Q62108,
CC       ECO:0000269|PubMed:15317815, ECO:0000269|PubMed:15358863,
CC       ECO:0000269|PubMed:19596852, ECO:0000269|PubMed:20628354,
CC       ECO:0000269|PubMed:23300088, ECO:0000269|PubMed:26679993}.
CC   -!- SUBUNIT: Interacts through its PDZ domains with ANO2 and NETO1 (By
CC       similarity). Interacts with KCNJ4 (PubMed:11997254). Interacts through
CC       its first two PDZ domains with GRIN2A, GRIN2B, GRIN2C and GRIN2D
CC       (PubMed:7569905). Interacts with ERBB4 (By similarity). Interacts with
CC       KCNA1, KCNA2, KCNA3 and KCNA4 (By similarity). Interacts with LRRC4 and
CC       LRRC4B (By similarity). Interacts with SYNGAP1 (PubMed:9581761).
CC       Interacts with ASIC3 (PubMed:15317815). Interacts with SEMA4C
CC       (PubMed:11134026). Interacts with CXADR (PubMed:15304526). Interacts
CC       with KCND2 (PubMed:11923279). Interacts (via first PDZ domain) with
CC       CRIPT (PubMed:9581762). Interacts through its first PDZ domain with
CC       GRIK2 and KCNA4 (By similarity). Interacts through its second PDZ
CC       domain with the PDZ domain of NOS1 or the C-terminus of CAPON
CC       (PubMed:23300088). Interacts through its third PDZ domain with NLGN1
CC       and CRIPT, and probably with NLGN2 and NLGN3 (By similarity). Interacts
CC       through its guanylate kinase-like domain with DLGAP1/GKAP, DLGAP2,
CC       DLGAP3, DLGAP4, MAP1A, BEGAIN and SIPA1L1 (PubMed:11502259,
CC       PubMed:9115257, PubMed:9756850, PubMed:9786987). Interacts through its
CC       guanylate kinase-like domain with KIF13B (By similarity). Isoform 2
CC       interacts through an L27 domain with HGS/HRS and the first L27 domain
CC       of CASK (By similarity). Interacts with ANKS1B (PubMed:17334360).
CC       Interacts with ADR1B (By similarity). May interact with HTR2A (By
CC       similarity). Interacts with ADAM22, KLHL17 and LGI1 (PubMed:16054660,
CC       PubMed:16990550, PubMed:20089912). Interacts with FRMPD4 (via C-
CC       terminus) (PubMed:19118189). Interacts with LRFN1 and LRFN2
CC       (PubMed:16495444, PubMed:16630835). Interacts with LRFN4 (By
CC       similarity). Interacts (via N-terminal tandem pair of PDZ domains) with
CC       GPER1 (via C-terminus tail motif); the interaction is direct and
CC       induces the increase of GPER1 protein levels residing at the plasma
CC       membrane surface in a estradiol-independent manner (PubMed:23300088).
CC       Interacts (via N-terminus tandem pair of PDZ domains) with NOS1 (via N-
CC       terminal domain) (PubMed:23300088). Interacts with SHANK3 (By
CC       similarity). Interacts with GPR85 (By similarity). Interacts with
CC       CACNG2 and MPP2 (via the SH3-Guanylate kinase-like sub-module)
CC       (PubMed:27756895). Interacts with ADGRB1 (By similarity). Found in a
CC       complex with PRR7 and GRIN1 (PubMed:27458189). Interacts (via PDZ3
CC       domain and to lesser degree via PDZ2 domain) with PRR7
CC       (PubMed:15629447, PubMed:27458189). Component of the postsynaptic
CC       hippocampal AMPA-type glutamate receptor (AMPAR) complex, at least
CC       composed of pore forming AMPAR subunits GRIA1, GRIA2 and GRIA3 and
CC       AMPAR auxiliary proteins SHISA6 and SHISA7. Interacts (via its first
CC       two PDZ domains) with SHISA6 and SHISA7 (via PDZ-binding motif); the
CC       interaction is direct (By similarity). Interacts (via PDZ domain 2)
CC       with SEMA4F (via PDZ-binding motif); this interaction may promote
CC       translocation of DLG4/SAP90 to the membrane (PubMed:11483650).
CC       Interacts with RPH3A and GRIN2A; this ternary complex regulates NMDA
CC       receptor composition at postsynaptic membranes (PubMed:26679993).
CC       Interacts with ABR and BCR (PubMed:20962234). Interacts with DGKI (via
CC       PDZ-binding motif); controls the localization of DGKI to the synapse
CC       (PubMed:21119615). Interacts with C9orf72, SMCR8 and RAB39B (By
CC       similarity). Interacts with ZDHHC5 (By similarity). Interacts with PTEN
CC       (via PDZ domain-binding motif); the interaction is induced by NMDA and
CC       is required for PTEN location at postsynaptic density
CC       (PubMed:20628354). Found in a complex with GRIA1, GRIA2, GRIA3, GRIA4,
CC       CACNG8 and CNIH2 (By similarity). Interacts with FAM81A; the
CC       interaction facilitates condensate formation via liquid-liquid phase
CC       separation (By similarity). {ECO:0000250|UniProtKB:P78352,
CC       ECO:0000250|UniProtKB:Q62108, ECO:0000269|PubMed:11134026,
CC       ECO:0000269|PubMed:11483650, ECO:0000269|PubMed:11502259,
CC       ECO:0000269|PubMed:11923279, ECO:0000269|PubMed:11997254,
CC       ECO:0000269|PubMed:14642282, ECO:0000269|PubMed:15304526,
CC       ECO:0000269|PubMed:15317815, ECO:0000269|PubMed:15629447,
CC       ECO:0000269|PubMed:16054660, ECO:0000269|PubMed:16495444,
CC       ECO:0000269|PubMed:16630835, ECO:0000269|PubMed:16990550,
CC       ECO:0000269|PubMed:17334360, ECO:0000269|PubMed:19118189,
CC       ECO:0000269|PubMed:20089912, ECO:0000269|PubMed:20628354,
CC       ECO:0000269|PubMed:20962234, ECO:0000269|PubMed:21119615,
CC       ECO:0000269|PubMed:23300088, ECO:0000269|PubMed:26679993,
CC       ECO:0000269|PubMed:27458189, ECO:0000269|PubMed:27756895,
CC       ECO:0000269|PubMed:7569905, ECO:0000269|PubMed:9115257,
CC       ECO:0000269|PubMed:9581761, ECO:0000269|PubMed:9581762,
CC       ECO:0000269|PubMed:9756850, ECO:0000269|PubMed:9786987}.
CC   -!- INTERACTION:
CC       P31016; P10608: Adrb2; NbExp=2; IntAct=EBI-375655, EBI-7090342;
CC       P31016; P70478: Apc; NbExp=2; IntAct=EBI-375655, EBI-631663;
CC       P31016; Q71RJ2: Cacng2; NbExp=2; IntAct=EBI-375655, EBI-8538384;
CC       P31016; Q9Z1T4: Cnksr2; NbExp=4; IntAct=EBI-375655, EBI-8548356;
CC       P31016; F1MAB7: Dgki; NbExp=4; IntAct=EBI-375655, EBI-8523614;
CC       P31016; O08560: Dgkz; NbExp=6; IntAct=EBI-375655, EBI-8570505;
CC       P31016; Q62696: Dlg1; NbExp=3; IntAct=EBI-375655, EBI-389325;
CC       P31016; P97836: Dlgap1; NbExp=9; IntAct=EBI-375655, EBI-80901;
CC       P31016; P97837: Dlgap2; NbExp=2; IntAct=EBI-375655, EBI-81025;
CC       P31016; P19490: Gria1; NbExp=5; IntAct=EBI-375655, EBI-371642;
CC       P31016; P35439: Grin1; NbExp=4; IntAct=EBI-375655, EBI-877897;
CC       P31016; Q00959: Grin2a; NbExp=5; IntAct=EBI-375655, EBI-630970;
CC       P31016; Q00960: Grin2b; NbExp=8; IntAct=EBI-375655, EBI-396905;
CC       P31016; Q9WVI4: Gucy1a2; NbExp=7; IntAct=EBI-375655, EBI-7665590;
CC       P31016; P20595: Gucy1b1; NbExp=2; IntAct=EBI-375655, EBI-7980539;
CC       P31016; Q5XIE8: Itm2b; NbExp=5; IntAct=EBI-375655, EBI-15348306;
CC       P31016; Q8K430: Klhl17; NbExp=2; IntAct=EBI-375655, EBI-7713653;
CC       P31016; Q460M5: Lrfn2; NbExp=3; IntAct=EBI-375655, EBI-877185;
CC       P31016; P70587: Lrrc7; NbExp=5; IntAct=EBI-375655, EBI-7798464;
CC       P31016; P34926: Map1a; NbExp=16; IntAct=EBI-375655, EBI-631571;
CC       P31016; O54857: Pten; NbExp=5; IntAct=EBI-375655, EBI-8074312;
CC       P31016; Q9WV48: Shank1; NbExp=3; IntAct=EBI-375655, EBI-80909;
CC       P31016; P28572: Slc6a9; NbExp=2; IntAct=EBI-375655, EBI-848783;
CC       P31016; P28572-2: Slc6a9; NbExp=4; IntAct=EBI-375655, EBI-848796;
CC       P31016; P30937: Sstr4; NbExp=3; IntAct=EBI-375655, EBI-7665959;
CC       P31016; Q9QUH6: Syngap1; NbExp=3; IntAct=EBI-375655, EBI-2310349;
CC       P31016; Q8R4T5: Tamalin; NbExp=3; IntAct=EBI-375655, EBI-7361884;
CC       P31016; Q6IN36: Wipf1; NbExp=5; IntAct=EBI-375655, EBI-6986245;
CC       P31016; P08588: ADRB1; Xeno; NbExp=2; IntAct=EBI-375655, EBI-991009;
CC       P31016; Q9P021: CRIPT; Xeno; NbExp=2; IntAct=EBI-375655, EBI-946968;
CC       P31016; Q12959-2: DLG1; Xeno; NbExp=9; IntAct=EBI-375655, EBI-357500;
CC       P31016; Q12879: GRIN2A; Xeno; NbExp=2; IntAct=EBI-375655, EBI-7249937;
CC       P31016; Q13224: GRIN2B; Xeno; NbExp=2; IntAct=EBI-375655, EBI-2256942;
CC       P31016; Q14957: GRIN2C; Xeno; NbExp=2; IntAct=EBI-375655, EBI-8285963;
CC       P31016; P22459: KCNA4; Xeno; NbExp=3; IntAct=EBI-375655, EBI-631235;
CC       P31016; P05480: Src; Xeno; NbExp=9; IntAct=EBI-375655, EBI-298680;
CC       P31016; Q80Z96: Vangl1; Xeno; NbExp=4; IntAct=EBI-375655, EBI-1750708;
CC       P31016; Q91ZD4: Vangl2; Xeno; NbExp=6; IntAct=EBI-375655, EBI-1750744;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10629226,
CC       ECO:0000269|PubMed:14642282, ECO:0000269|PubMed:9115257,
CC       ECO:0000305|PubMed:11997254}; Lipid-anchor
CC       {ECO:0000269|PubMed:10629226}; Cytoplasmic side
CC       {ECO:0000269|PubMed:10629226}. Postsynaptic density
CC       {ECO:0000269|PubMed:10629226, ECO:0000269|PubMed:11483650,
CC       ECO:0000269|PubMed:26679993, ECO:0000269|PubMed:27307232,
CC       ECO:0000269|PubMed:27756895, ECO:0000269|PubMed:9115257}. Synapse
CC       {ECO:0000269|PubMed:11483650, ECO:0000269|PubMed:11502259,
CC       ECO:0000269|PubMed:14642282, ECO:0000269|PubMed:19596852,
CC       ECO:0000269|PubMed:20089912, ECO:0000269|PubMed:20962234,
CC       ECO:0000269|PubMed:27307232, ECO:0000269|PubMed:8922396,
CC       ECO:0000269|PubMed:9115257}. Cytoplasm {ECO:0000269|PubMed:9115257}.
CC       Cell projection, axon {ECO:0000269|PubMed:20089912,
CC       ECO:0000269|PubMed:8922396}. Cell projection, dendritic spine
CC       {ECO:0000269|PubMed:10629226, ECO:0000269|PubMed:20628354,
CC       ECO:0000269|PubMed:26679993, ECO:0000269|PubMed:30021165}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:10629226,
CC       ECO:0000269|PubMed:11483650}. Presynapse {ECO:0000269|PubMed:8922396}.
CC       Note=High levels in postsynaptic density of neurons in the forebrain.
CC       Also in presynaptic region of inhibitory synapses formed by cerebellar
CC       basket cells on axon hillocks of Purkinje cells. Suppression of
CC       neuronal activity induces synaptic accumulation and clustering of DLG4
CC       (PubMed:19596852). {ECO:0000269|PubMed:19596852,
CC       ECO:0000269|PubMed:8922396}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PSD95-alpha;
CC         IsoId=P31016-1; Sequence=Displayed;
CC       Name=2; Synonyms=PSD95-beta;
CC         IsoId=P31016-2; Sequence=Not described;
CC   -!- TISSUE SPECIFICITY: Expressed in brain (at protein level)
CC       (PubMed:12151521, PubMed:20962234, PubMed:27307232). Detected in
CC       juxtaparanodal zones in the central nervous system and at nerve
CC       terminal plexuses of basket cells in the cerebellum (PubMed:20089912).
CC       Expressed in cerebrum (PubMed:27307232). Expressed in hippocampal
CC       neurons (at protein level) (PubMed:11502259, PubMed:12151521,
CC       PubMed:27307232, PubMed:27756895). Isoform 1 and isoform 2: highly
CC       expressed in cerebellum, cortex, hippocampus, and corpus striatum
CC       (PubMed:12151521, PubMed:20962234). {ECO:0000269|PubMed:11502259,
CC       ECO:0000269|PubMed:12151521, ECO:0000269|PubMed:20089912,
CC       ECO:0000269|PubMed:20962234, ECO:0000269|PubMed:27307232,
CC       ECO:0000269|PubMed:27756895}.
CC   -!- DEVELOPMENTAL STAGE: Expression gradually increases from late embryonic
CC       (E18) stage until adulthood. {ECO:0000269|PubMed:20962234}.
CC   -!- DOMAIN: The PDZ domain 3 mediates interaction with ADR1B.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The L27 domain near the N-terminus of isoform 2 is required for
CC       HGS/HRS-dependent targeting to postsynaptic density. {ECO:0000250}.
CC   -!- PTM: Palmitoylated (PubMed:10629226, PubMed:27307232). Palmitoylation
CC       is required for targeting to postsynaptic density, plasma membrane and
CC       synapses (PubMed:10629226, PubMed:27307232). Palmitoylation by ZDHHC2
CC       occurs when the synaptic activity decreases and induces DLG4 synaptic
CC       clustering (PubMed:19596852). Palmitoylation by ZDHHC15 regulates
CC       trafficking to the postsynaptic density and function in synaptogenesis
CC       (PubMed:15603741, PubMed:31189538). Palmitoylation may play a role in
CC       glutamate receptor GRIA1 synapse clustering (PubMed:27307232).
CC       Depalmitoylated by ABHD17A and ABHD17B and to a lesser extent by
CC       ABHD17C, ABHD12, ABHD13, LYPLA1 and LYPLA2 (PubMed:27307232). Undergoes
CC       rapid synaptic palmitoylation/depalmitoylation cycle during neuronal
CC       development which slows down in mature neurons (PubMed:27307232).
CC       {ECO:0000269|PubMed:10629226, ECO:0000269|PubMed:15603741,
CC       ECO:0000269|PubMed:19596852, ECO:0000269|PubMed:27307232,
CC       ECO:0000269|PubMed:31189538}.
CC   -!- PTM: Ubiquitinated by MDM2 in response to NMDA receptor activation,
CC       leading to proteasome-mediated degradation of DLG4 which is required
CC       for AMPA receptor endocytosis. {ECO:0000269|PubMed:14642282}.
CC   -!- SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M96853; AAA41971.1; -; mRNA.
DR   EMBL; X66474; CAA47103.1; -; mRNA.
DR   EMBL; U77090; AAB38270.1; -; mRNA.
DR   PIR; A45436; A45436.
DR   PIR; JH0800; JH0800.
DR   RefSeq; NP_062567.1; NM_019621.1. [P31016-1]
DR   PDB; 1BE9; X-ray; 1.82 A; A=302-430.
DR   PDB; 1BFE; X-ray; 2.30 A; A=302-402.
DR   PDB; 1IU0; NMR; -; A=61-151.
DR   PDB; 1IU2; NMR; -; A=61-151.
DR   PDB; 1JXM; X-ray; 2.00 A; A=430-724.
DR   PDB; 1JXO; X-ray; 2.30 A; A/B=430-724.
DR   PDB; 1KJW; X-ray; 1.80 A; A=430-724.
DR   PDB; 1QLC; NMR; -; A=155-249.
DR   PDB; 1RGR; NMR; -; A=62-154.
DR   PDB; 1TP3; X-ray; 1.99 A; A=302-402.
DR   PDB; 1TP5; X-ray; 1.54 A; A=302-402.
DR   PDB; 1TQ3; X-ray; 1.89 A; A=302-402.
DR   PDB; 2KA9; NMR; -; A=61-249.
DR   PDB; 2MHO; NMR; -; A=60-155.
DR   PDB; 2XKX; Other; 22.90 A; A/B=1-724.
DR   PDB; 3GSL; X-ray; 2.05 A; A/B=61-249.
DR   PDB; 3WP0; X-ray; 2.04 A; A=531-713.
DR   PDB; 3WP1; X-ray; 2.80 A; B=531-713.
DR   PDB; 5B64; X-ray; 2.70 A; A=531-713.
DR   PDB; 5D13; X-ray; 2.15 A; A/B/C/D=302-402.
DR   PDB; 5GNV; X-ray; 2.60 A; A=531-713.
DR   PDB; 5HDY; X-ray; 1.80 A; A=302-402.
DR   PDB; 5HEB; X-ray; 1.65 A; A=302-402.
DR   PDB; 5HED; X-ray; 1.70 A; A=302-402.
DR   PDB; 5HET; X-ray; 2.00 A; A=302-402.
DR   PDB; 5HEY; X-ray; 1.50 A; A=302-402.
DR   PDB; 5HF1; X-ray; 1.75 A; A=302-402.
DR   PDB; 5HF4; X-ray; 1.75 A; A=302-402.
DR   PDB; 5HFB; X-ray; 1.62 A; A=302-402.
DR   PDB; 5HFC; X-ray; 1.85 A; A=302-402.
DR   PDB; 5HFD; X-ray; 1.60 A; A=302-402.
DR   PDB; 5HFE; X-ray; 1.80 A; A=302-402.
DR   PDB; 5HFF; X-ray; 1.75 A; A=302-402.
DR   PDB; 5MZ7; X-ray; 1.53 A; A/B/C/D=303-402.
DR   PDB; 5W72; NMR; -; A=301-402.
DR   PDB; 5YPO; X-ray; 2.29 A; A/B=531-713.
DR   PDB; 5YPR; X-ray; 2.35 A; A=426-721.
DR   PDB; 7CQF; X-ray; 1.80 A; A=309-422.
DR   PDB; 7F7G; X-ray; 2.45 A; A/B=531-713.
DR   PDB; 7F7I; X-ray; 2.60 A; A/B/C/D/E/F=531-713.
DR   PDBsum; 1BE9; -.
DR   PDBsum; 1BFE; -.
DR   PDBsum; 1IU0; -.
DR   PDBsum; 1IU2; -.
DR   PDBsum; 1JXM; -.
DR   PDBsum; 1JXO; -.
DR   PDBsum; 1KJW; -.
DR   PDBsum; 1QLC; -.
DR   PDBsum; 1RGR; -.
DR   PDBsum; 1TP3; -.
DR   PDBsum; 1TP5; -.
DR   PDBsum; 1TQ3; -.
DR   PDBsum; 2KA9; -.
DR   PDBsum; 2MHO; -.
DR   PDBsum; 2XKX; -.
DR   PDBsum; 3GSL; -.
DR   PDBsum; 3WP0; -.
DR   PDBsum; 3WP1; -.
DR   PDBsum; 5B64; -.
DR   PDBsum; 5D13; -.
DR   PDBsum; 5GNV; -.
DR   PDBsum; 5HDY; -.
DR   PDBsum; 5HEB; -.
DR   PDBsum; 5HED; -.
DR   PDBsum; 5HET; -.
DR   PDBsum; 5HEY; -.
DR   PDBsum; 5HF1; -.
DR   PDBsum; 5HF4; -.
DR   PDBsum; 5HFB; -.
DR   PDBsum; 5HFC; -.
DR   PDBsum; 5HFD; -.
DR   PDBsum; 5HFE; -.
DR   PDBsum; 5HFF; -.
DR   PDBsum; 5MZ7; -.
DR   PDBsum; 5W72; -.
DR   PDBsum; 5YPO; -.
DR   PDBsum; 5YPR; -.
DR   PDBsum; 7CQF; -.
DR   PDBsum; 7F7G; -.
DR   PDBsum; 7F7I; -.
DR   AlphaFoldDB; P31016; -.
DR   BMRB; P31016; -.
DR   EMDB; EMD-1761; -.
DR   SMR; P31016; -.
DR   BioGRID; 248135; 34.
DR   CORUM; P31016; -.
DR   DIP; DIP-29264N; -.
DR   ELM; P31016; -.
DR   IntAct; P31016; 353.
DR   MINT; P31016; -.
DR   STRING; 10116.ENSRNOP00000074184; -.
DR   ChEMBL; CHEMBL3797015; -.
DR   iPTMnet; P31016; -.
DR   PhosphoSitePlus; P31016; -.
DR   SwissPalm; P31016; -.
DR   jPOST; P31016; -.
DR   PaxDb; 10116-ENSRNOP00000059045; -.
DR   ABCD; P31016; 3 sequenced antibodies.
DR   GeneID; 29495; -.
DR   KEGG; rno:29495; -.
DR   UCSC; RGD:68424; rat. [P31016-1]
DR   AGR; RGD:68424; -.
DR   CTD; 1742; -.
DR   RGD; 68424; Dlg4.
DR   VEuPathDB; HostDB:ENSRNOG00000018526; -.
DR   eggNOG; KOG0708; Eukaryota.
DR   HOGENOM; CLU_001715_4_2_1; -.
DR   InParanoid; P31016; -.
DR   OrthoDB; 2879721at2759; -.
DR   PhylomeDB; P31016; -.
DR   Reactome; R-RNO-399719; Trafficking of AMPA receptors.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-451308; Activation of Ca-permeable Kainate Receptor.
DR   Reactome; R-RNO-5625900; RHO GTPases activate CIT.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-5682910; LGI-ADAM interactions.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   EvolutionaryTrace; P31016; -.
DR   PRO; PR:P31016; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000018526; Expressed in frontal cortex and 20 other cell types or tissues.
DR   ExpressionAtlas; P31016; baseline and differential.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; ISS:BHF-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; ISS:BHF-UCL.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0044300; C:cerebellar mossy fiber; ISO:RGD.
DR   GO; GO:0030863; C:cortical cytoskeleton; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0032839; C:dendrite cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0044307; C:dendritic branch; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0044224; C:juxtaparanode region of axon; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0044306; C:neuron projection terminus; ISS:BHF-UCL.
DR   GO; GO:0044309; C:neuron spine; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:1990635; C:proximal dendrite; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:BHF-UCL.
DR   GO; GO:0033130; F:acetylcholine receptor binding; IDA:RGD.
DR   GO; GO:0031697; F:beta-1 adrenergic receptor binding; IPI:UniProtKB.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0031748; F:D1 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0005109; F:frizzled binding; IPI:ARUK-UCL.
DR   GO; GO:0035254; F:glutamate receptor binding; IPI:BHF-UCL.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0019900; F:kinase binding; ISO:RGD.
DR   GO; GO:0019894; F:kinesin binding; IPI:RGD.
DR   GO; GO:0097109; F:neuroligin family protein binding; IPI:BHF-UCL.
DR   GO; GO:0031812; F:P2Y1 nucleotide receptor binding; IPI:BHF-UCL.
DR   GO; GO:0030165; F:PDZ domain binding; IMP:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:SynGO-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0098919; F:structural constituent of postsynaptic density; IDA:SynGO.
DR   GO; GO:0097113; P:AMPA glutamate receptor clustering; IMP:BHF-UCL.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0035865; P:cellular response to potassium ion; ISO:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0097061; P:dendritic spine organization; IMP:UniProtKB.
DR   GO; GO:0045184; P:establishment of protein localization; ISS:BHF-UCL.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IBA:GO_Central.
DR   GO; GO:0035641; P:locomotory exploration behavior; ISS:BHF-UCL.
DR   GO; GO:0002091; P:negative regulation of receptor internalization; IDA:UniProtKB.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISS:BHF-UCL.
DR   GO; GO:0045161; P:neuronal ion channel clustering; TAS:UniProtKB.
DR   GO; GO:0099645; P:neurotransmitter receptor localization to postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:1904719; P:positive regulation of AMPA glutamate receptor clustering; IMP:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IMP:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:BHF-UCL.
DR   GO; GO:0150012; P:positive regulation of neuron projection arborization; IGI:ARUK-UCL.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:ARUK-UCL.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IMP:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IDA:BHF-UCL.
DR   GO; GO:0098970; P:postsynaptic neurotransmitter receptor diffusion trapping; IMP:SynGO.
DR   GO; GO:0035418; P:protein localization to synapse; IMP:UniProtKB.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISS:BHF-UCL.
DR   GO; GO:0097120; P:receptor localization to synapse; IMP:BHF-UCL.
DR   GO; GO:2000821; P:regulation of grooming behavior; ISS:BHF-UCL.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISS:BHF-UCL.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; IMP:UniProtKB.
DR   GO; GO:2000310; P:regulation of NMDA receptor activity; IDA:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; ISS:BHF-UCL.
DR   GO; GO:0016188; P:synaptic vesicle maturation; ISS:BHF-UCL.
DR   GO; GO:0071625; P:vocalization behavior; ISS:BHF-UCL.
DR   CDD; cd00071; GMPK; 1.
DR   CDD; cd00992; PDZ_signaling; 3.
DR   CDD; cd12030; SH3_DLG4; 1.
DR   Gene3D; 2.30.42.10; -; 3.
DR   Gene3D; 3.30.63.10; Guanylate Kinase phosphate binding domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR019583; DLG1-4_PDZ_assoc.
DR   InterPro; IPR016313; DLG1-like.
DR   InterPro; IPR019590; DLG1_PEST_dom.
DR   InterPro; IPR008145; GK/Ca_channel_bsu.
DR   InterPro; IPR008144; Guanylate_kin-like_dom.
DR   InterPro; IPR020590; Guanylate_kinase_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR050614; Synaptic_Scaffolding_LAP-MAGUK.
DR   PANTHER; PTHR23119; DISCS LARGE; 1.
DR   PANTHER; PTHR23119:SF33; DISKS LARGE HOMOLOG 4; 1.
DR   Pfam; PF00625; Guanylate_kin; 1.
DR   Pfam; PF10608; MAGUK_N_PEST; 1.
DR   Pfam; PF00595; PDZ; 3.
DR   Pfam; PF10600; PDZ_assoc; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PIRSF; PIRSF001741; MAGUK_DLGH; 1.
DR   SMART; SM00072; GuKc; 1.
DR   SMART; SM01277; MAGUK_N_PEST; 1.
DR   SMART; SM00228; PDZ; 3.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 3.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS00856; GUANYLATE_KINASE_1; 1.
DR   PROSITE; PS50052; GUANYLATE_KINASE_2; 1.
DR   PROSITE; PS50106; PDZ; 3.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Cytoplasm; Direct protein sequencing; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Reference proteome; Repeat; SH3 domain; Synapse;
KW   Ubl conjugation.
FT   CHAIN           1..724
FT                   /note="Disks large homolog 4"
FT                   /id="PRO_0000094562"
FT   DOMAIN          65..151
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          160..246
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          313..393
FT                   /note="PDZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          428..498
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          534..709
FT                   /note="Guanylate kinase-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00100"
FT   REGION          15..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         73
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   MOD_RES         240
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         295
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   MOD_RES         418
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         420
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         422
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   MOD_RES         449
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         480
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   MOD_RES         580
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   MOD_RES         606
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   MOD_RES         654
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         715
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62108"
FT   LIPID           3
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:10629226,
FT                   ECO:0000269|PubMed:27307232"
FT   LIPID           5
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:10629226,
FT                   ECO:0000269|PubMed:27307232"
FT   MUTAGEN         3
FT                   /note="C->S: Loss of palmitoylation and targeting to
FT                   postsynaptic density."
FT                   /evidence="ECO:0000269|PubMed:10629226,
FT                   ECO:0000269|PubMed:27307232"
FT   MUTAGEN         5
FT                   /note="C->S: Loss of palmitoylation and targeting to
FT                   postsynaptic density."
FT                   /evidence="ECO:0000269|PubMed:10629226,
FT                   ECO:0000269|PubMed:27307232"
FT   MUTAGEN         13..24
FT                   /note="Missing: Greatly reduced ubiquitination."
FT                   /evidence="ECO:0000269|PubMed:14642282"
FT   CONFLICT        61
FT                   /note="M -> L (in Ref. 2; CAA47103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        78
FT                   /note="S -> T (in Ref. 2; CAA47103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        177..182
FT                   /note="GVGNQH -> ALGTSI (in Ref. 2; CAA47103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        200
FT                   /note="A -> G (in Ref. 2; CAA47103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        254
FT                   /note="S -> T (in Ref. 2; CAA47103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        540..555
FT                   /note="LGPTKDRANDDLLSEF -> SLDPPKTVPTMIFSPSS (in Ref. 2;
FT                   CAA47103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        623..625
FT                   /note="GKH -> RDQ (in Ref. 4; AAB38270)"
FT                   /evidence="ECO:0000305"
FT   STRAND          61..69
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:2KA9"
FT   STRAND          74..80
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          82..85
FT                   /evidence="ECO:0007829|PDB:1IU0"
FT   STRAND          88..91
FT                   /evidence="ECO:0007829|PDB:1IU0"
FT   STRAND          94..99
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:2KA9"
FT   HELIX           104..108
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          116..120
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   HELIX           125..127
FT                   /evidence="ECO:0007829|PDB:1IU2"
FT   HELIX           130..138
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          142..151
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          156..166
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          172..178
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          189..194
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   HELIX           199..203
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          211..215
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          221..224
FT                   /evidence="ECO:0007829|PDB:1QLC"
FT   HELIX           225..233
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   STRAND          237..247
FT                   /evidence="ECO:0007829|PDB:3GSL"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:1TP5"
FT   STRAND          312..317
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   TURN            319..321
FT                   /evidence="ECO:0007829|PDB:5MZ7"
FT   STRAND          325..328
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   STRAND          331..334
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   STRAND          337..341
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   HELIX           348..350
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   STRAND          357..362
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   HELIX           372..380
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   STRAND          384..392
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   HELIX           394..398
FT                   /evidence="ECO:0007829|PDB:5HEY"
FT   STRAND          410..412
FT                   /evidence="ECO:0007829|PDB:1BE9"
FT   STRAND          418..420
FT                   /evidence="ECO:0007829|PDB:1BE9"
FT   STRAND          431..437
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           441..445
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          449..451
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          459..464
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          467..475
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          486..489
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           491..499
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   TURN            504..507
FT                   /evidence="ECO:0007829|PDB:1JXO"
FT   STRAND          523..530
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          537..541
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           544..554
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   TURN            556..558
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          559..561
FT                   /evidence="ECO:0007829|PDB:7F7G"
FT   STRAND          565..568
FT                   /evidence="ECO:0007829|PDB:7F7G"
FT   TURN            576..578
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           586..594
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   TURN            595..597
FT                   /evidence="ECO:0007829|PDB:5GNV"
FT   STRAND          598..604
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          607..612
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           613..621
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          625..628
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           634..640
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          646..650
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           655..661
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          663..665
FT                   /evidence="ECO:0007829|PDB:1JXM"
FT   HELIX           667..684
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           685..687
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          689..692
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   HELIX           697..711
FT                   /evidence="ECO:0007829|PDB:1KJW"
FT   STRAND          714..719
FT                   /evidence="ECO:0007829|PDB:1KJW"
SQ   SEQUENCE   724 AA;  80465 MW;  7922D4E8E0F9AD85 CRC64;
     MDCLCIVTTK KYRYQDEDTP PLEHSPAHLP NQANSPPVIV NTDTLEAPGY ELQVNGTEGE
     MEYEEITLER GNSGLGFSIA GGTDNPHIGD DPSIFITKII PGGAAAQDGR LRVNDSILFV
     NEVDVREVTH SAAVEALKEA GSIVRLYVMR RKPPAEKVME IKLIKGPKGL GFSIAGGVGN
     QHIPGDNSIY VTKIIEGGAA HKDGRLQIGD KILAVNSVGL EDVMHEDAVA ALKNTYDVVY
     LKVAKPSNAY LSDSYAPPDI TTSYSQHLDN EISHSSYLGT DYPTAMTPTS PRRYSPVAKD
     LLGEEDIPRE PRRIVIHRGS TGLGFNIVGG EDGEGIFISF ILAGGPADLS GELRKGDQIL
     SVNGVDLRNA SHEQAAIALK NAGQTVTIIA QYKPEEYSRF EAKIHDLREQ LMNSSLGSGT
     ASLRSNPKRG FYIRALFDYD KTKDCGFLSQ ALSFRFGDVL HVIDAGDEEW WQARRVHSDS
     ETDDIGFIPS KRRVERREWS RLKAKDWGSS SGSQGREDSV LSYETVTQME VHYARPIIIL
     GPTKDRANDD LLSEFPDKFG SCVPHTTRPK REYEIDGRDY HFVSSREKME KDIQAHKFIE
     AGQYNSHLYG TSVQSVREVA EQGKHCILDV SANAVRRLQA AHLHPIAIFI RPRSLENVLE
     INKRITEEQA RKAFDRATKL EQEFTECFSA IVEGDSFEEI YHKVKRVIED LSGPYIWVPA
     RERL
//
